Astragaloside IV treatment increases lncsirt1 AS and lncsirt1 AS and is validated to enhance the stability of sirt1 and increase sirt1 expression, thereby preventing IPF. 103. Here, SIRT1 is linked to idiopathic pulmonary fibrosis.